Medivation to Present at J.P. Morgan Healthcare Conference
(firmenpresse) - SAN FRANCISCO, CA -- (Marketwired) -- 01/04/16 -- Medivation, Inc. (NASDAQ: MDVN) today announced that
David Hung, M.D., founder, president and chief executive officer, will present at the 34th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2016, at 3:00pm PT at the Westin St. Francis Hotel in San Francisco, CA.
Individuals may access the live audio webcast by visiting: . A replay of the webcast will be available on the Company's website for 30 days following the live event.
Medivation, Inc. is a biopharmaceutical company focused on the development and commercialization of medically innovative therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at .
Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 04.01.2016 - 21:10 Uhr
Sprache: Deutsch
News-ID 442233
Anzahl Zeichen: 0
contact information:
Town:
SAN FRANCISCO, CA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 225 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Medivation to Present at J.P. Morgan Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Medivation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
